Why the study?
Does biomarker profiling by Nuclear Magnetic Resonance Spectroscopy improve prediction of all-cause mortality compared to established risk factors in 17,345 persons?
Does biomarker profiling by Nuclear Magnetic Resonance Spectroscopy improve prediction of all-cause mortality compared to established risk factors in 17,345 persons?
Biomarker profiling by NMR spectroscopy improves the prediction of short-term all-cause mortality beyond established risk factors.
Answers are grounded in this paper and cite their sources.
May enhance short-term mortality prediction; hypothesis-generating and requires prospective validation before clinical adoption.
Biomarker associations with cardiovascular, nonvascular, and cancer mortality suggest novel systemic connectivities across seemingly disparate morbidities. The biomarker profiling improved prediction of the short-term risk of death from all causes above established risk factors. Further investigations are needed to clarify the biological mechanisms and the utility of these biomarkers for guiding screening and prevention.
No takes yet. Share an insight, caveat, or question.
Fischer et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: